Buchumschlag

Exploiting the unique properties of nanobodies: enhancing therapeutics, drug delivery, and targeted diagnostics

Nanobodies (Nbs) are genetically engineered single domain antibodies derived from heavy chain-only antibodies (HcAbs) found in camelid species. These monomeric antibody fragments are smaller and have lower molecular weight compared with conventional antibodies, while retaining full antigen-binding s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Blank, Lisa (VerfasserIn) , Pander, Giulia (VerfasserIn) , Mühlberg, Eric (VerfasserIn) , Mier, Walter (VerfasserIn) , Uhl, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: December 2025
In: Drug discovery today
Year: 2025, Jahrgang: 30, Heft: 12, Pages: 1-14
ISSN:1878-5832
DOI:10.1016/j.drudis.2025.104524
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.drudis.2025.104524
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1359644625002375
Volltext
Verfasserangaben:Lisa Blank, Giulia Pander, Eric Mühlberg, Walter Mier, Philipp Uhl
Beschreibung
Zusammenfassung:Nanobodies (Nbs) are genetically engineered single domain antibodies derived from heavy chain-only antibodies (HcAbs) found in camelid species. These monomeric antibody fragments are smaller and have lower molecular weight compared with conventional antibodies, while retaining full antigen-binding specificity, endowing them with unique structural and functional properties. As in vitro diagnostics, they can aid pathogen detection and biomarker identification. In vivo, their rapid clearance and deep tissue penetration enable radio-imaging with short half-life radionuclides, reducing patient exposure. Therapeutically, Nbs are being explored for cancer, neurodegenerative, and infectious diseases. However, their short serum half-life is challenging, prompting strategies to extend circulation time without compromising their benefits. Despite these hurdles, the high specificity, low immunogenicity, and versatility of Nbs position them as promising tools across diverse applications.
Beschreibung:Online verfügbar: 1. November 2025, Artikelversion: 17. November 2025
Gesehen am 26.01.2026
Beschreibung:Online Resource
ISSN:1878-5832
DOI:10.1016/j.drudis.2025.104524

Ähnliche Einträge